Ifinwil 192 mg
Ifinwil 192 mg is a medicine authorised by Swissmedic under authorisation number 68708. The authorisation holder is Norgine AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 26 June 2025 and the authorisation is limited until 25 June 2030. ATC code L01XX79 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68708 |
|---|---|
| Name | Ifinwil 192 mg |
| Full name | Ifinwil 192 mg, Tabletten |
| Authorisation holder | Norgine AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XX79 |
| First authorisation | 26 June 2025 |
| Authorisation validity | 25 June 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ifinwil 192 mg, Tabletten | A | 26 June 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 100 | Tablette(n) | L01XX79 | 07.16.4. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Ifinwil 192 mg authorised in Switzerland?
Yes. Ifinwil 192 mg is authorised by Swissmedic under authorisation number 68708, data as of 01 September 2026. The authorisation is limited until 25 June 2030.
Which dispensing category does Ifinwil 192 mg have?
Ifinwil 192 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Ifinwil 192 mg?
The authorisation holder is Norgine AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.